KIM, D. D. H. Tyrosine kinase inhibitors for the frontline management of CML: an overview. Canadian Hematology Today, Toronto, Canada, v. 2, n. 1, p. 22–26, 2023. DOI: 10.58931/cht.2023.2124. Disponível em: https://canadianhematologytoday.com/article/view/2-1-4-kim. Acesso em: 2 mar. 2024.